Vaping cessation pill under trial: varenicline tested on 326 adults
NCT ID NCT07040566
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the medication varenicline can help adults quit using e-cigarettes. Researchers will compare varenicline to a placebo in 326 people who vape daily. The main goal is to see if more participants can stop vaping for at least a week by the 12-week mark, with a follow-up at 26 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for E-CIGARETTE USE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hollings Cancer Center at MUSC (HCC)
RECRUITINGCharleston, South Carolina, 29425, United States
-
Yale Cancer Center/Smilow Cancer Hospital at Yale-New Haven
RECRUITINGNew Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Nicotine-Free cigarette break the habit?
- Can sleep patterns explain racial gaps in smoking cravings?
- Quit smoking from your couch: teleconsultation put to the test
- Do newer IQOS devices change how people puff? study investigates
- Scientists probe the mechanics of E-Cigarette withdrawal to find better quit strategies
- Could a sleep medication curb nicotine cravings?